发明名称 |
Prevention of bacterial growth and biofilm formation by ligands that act on cannabinoidergic systems |
摘要 |
A group of antimicrobial compounds shows effectiveness for preventing bacterial growth and bio film formation. In particular, the compounds are effective for preventing the growth of gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (“MRSA”) bacteria. The compounds include naturally-occurring compounds such as linoleyl ethanolamide, noladin ether, and anandamide, and man-made compounds such as CP55,640 [(−)-cis-3-[2-Hydroxy-4-(l,l-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol] and O-2050 [(6aR,10aR)-3-(l-Methanesulfonylamino-4-hexyn-6-yl)-6a,7,10,1Oa-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran]. Because these antibacterial compounds have unique modes of action and/or unique chemical scaffolds compared to traditional antibiotics, they are extremely useful against bacteria having resistances to antibiotics. |
申请公布号 |
US9192598(B2) |
申请公布日期 |
2015.11.24 |
申请号 |
US200913000147 |
申请日期 |
2009.06.25 |
申请人 |
University of North Texas Health Science Center at Fort Worth;The Texas A&M University System |
发明人 |
Schetz John A.;Hoger Sally A. |
分类号 |
A01N37/18;A61K38/00;A61P31/04;A61K38/04;A01N43/00;A61K31/33;A01N55/02;A61K31/555;A01N43/16;A61K31/35;A01N41/06;A61K31/18;A61K31/16;A01N33/02;A61K31/135;A01N31/00;A61K31/045;A01N33/24;A61K31/04;A01N27/00;A61K31/015;A61K31/352;A01N31/02;A01N31/08;A01N37/20;A61K31/05;A61K31/08;A61K31/164;A61K45/06;A61L15/44 |
主分类号 |
A01N37/18 |
代理机构 |
Jackson Walker L.L.P. |
代理人 |
Jackson Walker L.L.P. |
主权项 |
1. A method of inhibiting or reducing gram positive bacterial growth or gram positive bacterial biofilm formation on a surface in need of an anti-infective treatment, comprising:
locating the surface in need of the anti-infective treatment; and contacting the surface in need of the anti-infective coating treatment with an effective amount of a cannabinoidergic-system-acting compound dissolved in an appropriate solvent for inhibiting or reducing gram positive bacterial growth or gram positive bacterial biofilm formation, wherein the cannabinoidergic-system-acting compound comprises (−)-cis-3-[2-Hydroxy-4-(1,1-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol having a structure of: |
地址 |
Fort Worth TX US |